ALDH1A1 and central nervous system cancer: Recent research demonstrated that KIF4A knock-down can suppress the glioma stem cells marker expression including CD133, ALDH1A1, and ALDH1A3, meanwhile, KIF4A over-expression can promote the epithelial-to-mesenchymal transition (EMT) of glioma [29].